Study protocol of a single-arm phase 2 study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in colorectal cancer patients receiving adjuvant chemotherapy with capecitabine plus oxaliplatin (T-CRACC study)

Table 1 The assessment schedule

		Chemotherapy (cycles)
	Pre-treatment	1	2	3	4	5	6	7	8
Performance status	•	•	•	•	•	•	•	•	•
Blood test	•	•	•	•	•	•	•	•	•
Hand foot syndrome		•	•	•	•	•	•	•	•
Adverse events		•	•	•	•	•	•	•	•
Self report (adverse evens)		•	•	•	•	•	•	•	•
Self report (self-adherence)		•	•	•	•	•	•	•	•
Dose of chemotherapy		•	•	•	•	•	•	•	•
Postponement of chemotherapy		•	•	•	•	•	•	•	•
Discontinuation of chemotherapy		•	•	•	•	•	•	•	•

ISSN: 1471-230X